No Detail Found!

HCC control by lycorine-based restraining of the MiR-224- 5p/COLEC10 axis

Author(s)
Cai Chen Faculty of Medicine, Xinyang Vocational and Technical College,Xinyang,China
Junjie Zhao Faculty of Medicine, Xinyang Vocational and Technical College,Xinyang,China
Bo Qiu Faculty of Medicine, Xinyang Vocational and Technical College,Xinyang,China
Abstract
Lycorine (LYC), as a natural alkaloid, possesses various significant biological activities. This study aims to investigate the impact and underlying mechanisms of LYC on the malignant progression of hepatocellular carcinoma (HCC). The levels of miR-224-5p, collectin subfamily member 10 (COLEC10) and inflammatory factors were quantified by RT-qPCR. The levels of COLEC10 and EMT relevant proteins were identified by Western blotting. Effects of LYC on the biological behaviors of HCC cells were assessed. The Dual-Luciferase reporter assay was used to verify the targeting relationship between miR-224-5p and COLEC10. Additionally, A subcutaneous xenograft model of HCC was created in nude mice. HCC tissues and cells exhibited elevated level of miR-224-5p, while COLEC10 was lower. Overexpression miR-224-5p enhanced HCC cells proliferation, migration, invasion, EMT and inflammatory response, while suppressed apoptosis. Moreover, miR-224-5p targeted the expression of COLEC10 negatively. COLEC10 silenced could offset the suppression of HCC advancement induced by silenced miR-224-5p. While LYC down regulated miR224-5p level and inhibited the HCC malignant progression. In conclusion, LYC can down regulate the levels of miR224-5p, upregulate the levels of COLEC10 and thus inhibit the malignant progression of HCC.
Publication Details
Page(s) 1093-1105
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 5, Year: 2024

Request the full text from PASTIC

Keywords
Hepatocellular carcinoma, Proliferation, Lycorine, Collectin subfamily member 10, miR-224-5p
References
Abbas AK,Trotta EDRS,Marson A,Bluestone JA .2018 .Revisiting IL-2: Biology and therapeutic prospects. Science Immunology, 3(25) : eaat1482.
Alkreathy HM,Esmat A .2022 .Lycorine ameliorates thioacetamide-induced hepatic fibrosis in rats: Emphasis on antioxidant, anti-inflammatory, and STAT3 inhibition effects. Pharmaceuticals (Basel), 15(3) : 369.
Ayuso C,Rimola J,Vilana R,Burrel M,Darnell A,García-Criado Á,Bianchi L,Belmonte E,Caparroz C,Barrufet M,Bruix J,Bru C .2018 .Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines. Eur. J. Radiol., 101 : 72-81.
Bae J,Liu L,Moore C,Hsu E,Zhang A,Ren Z,Sun Z,Wang X,Zhu J,Shen J,Qiao J,Fu YX .2022 .IL-2 delivery by engineered mesenchymal stem cells reinvigorates CD8+ T cells to overcome immunotherapy resistance in cancer. Nat. Cell Biol, 24(12) : 1754-1765.
Cai MN,Chen DM,Xiao LX,Li SS,Liao CH,Li J,Huang ZX,Wang JL,Gu YR,Gu L,Huang YH,Lian YF .2023 .COLEC10 induces endoplasmic reticulum stress by occupying GRP78 and inhibits hepatocellular carcinoma. Lab. Invest, 103(7) : 100130.
Chedid MF,Kruel CRP,Pinto MA,Grezzana-Filho TJM,Leipnitz I,Kruel CDP,Scaffaro LA,Chedid AD .2017 .Hepatocellular carcinoma: Diagnosis and operative management. Arquivos brasileiros de cirurgia digestiva: ABCD = Brazilian archives of digestive surgery. , 30(4) : 272-278.
Chen T,You Y,Jiang H,Wang ZZ H .2017 .Epithelialmesenchymal transition (EMT): A biological process in the development, stem cell differentiation and tumorigenesis. J. Cell Physiol, 232(12) : 3261-3272.
Cruceriu D,Baldasici O,Balacescu O,BerindanNeagoe I .2020 .The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: Molecular insights and therapeutic approaches. Cell Oncol, 43(1) : 1-18.
Sotto Di,Valipour A,Azari M,Di A,Irannejad H Giacomo S .2023 .Benzoindolizidine alkaloids tylophorine and lycorine and their analogues with antiviral, anti-inflammatory, and anticancer properties: Promises and challenges. Biomedicines, 11(10) : 2619.
Diener C,Keller A,Meese E .2022 .Emerging concepts of miRNA therapeutics: From cells to clinic. Trends Genet, 38(6) : 613-626.
Ding H,Wang G,Yu Z,Sun H,Wang L H .2022 .Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway. Biomed, 155 : 113683.
Foglia B,Turato C,Cannito S C .2023 .Hepatocellular carcinoma: Latest research in pathogenesis, detection and treatment. Int. J. Mol. Sci, 24(15) : 12224.
Hartke J,Johnson M,Ghabril M M .2017 .The diagnosis and treatment of hepatocellular carcinoma. Semin. Diagn. Pathol., 34(2) : 153-159.
Hassanipour S,Vali M,Gaffari-Fam S,Nikbakht HA,Abdzadeh E,Joukar F,Pourshams A,Shafaghi A,Malakoutikhah M,Arab-Zozani M,Salehiniya H,Mansour-Ghanaei F .2020 .The survival rate of hepatocellular carcinoma in Asian countries: A systematic review and meta-analysis. EXCLI Journal, 19 : 108-130.
He B,Zhao Z,Cai Q,Zhang Y,Zhang P,Shi S,Xie H,Peng X,Yin W,Tao Y,Wang X Y .2020 .miRNAbased biomarkers, therapies and resistance in Cancer. Int J Biol Sci., 16(14) : 2628-2647.
Hu M,Yu Z,Mei P,Li J,Luo D,Zhang H,Zhou M,Liang F,Chen R F .2020 .Lycorine Induces autophagy-associated apoptosis by targeting MEK2 and enhances vemurafenib activity in colorectal cancer. Aging, 12(1) : 138-155.
Hu Z,Zhao Y,Mang Y,Zhu J,Yu L,Li L,Ran J .2023 .MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24. Life Sciences, 325 : 121773.
Jorgovanovic D,Song M,Wang L,Zhang Y .2020 .Roles of IFN-γ in tumor progression and regression: A review. Biomarker research, 8 : 49.
Li D,Zhang J,Li J .2020 .Role of miRNA sponges in hepatocellular carcinoma. Clin. Chim. Acta., 500 : 10-19.
Li Y,Jiang A .2020 .ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB6. Cancer Biol Ther. , 21 : 647-655.
Li Z,Zhou Q,Liu X,Li Y,Fan X,Liu G .2022 .Lycorine upregulates the expression of RMB10, promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells. Int. J. Mol. Med, 50(6) : 145.
Li Z,Wu L,Tan W,Zhang K,Lin Q,Zhu J,Tu C,Lv X,Jiang C .2021 .MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3. , 23 : 100345.
Mittal V .2018 .Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol., 13 : 395-412.
Nagaraju GP,Dariya B,Kasa P,Peela S,El-Rayes BF .2022 .Epigenetics in hepatocellular carcinoma. Semin. Cancer Biol, 86 : 622-632.
Oura K,Morishita A,Masaki T .2020 .Molecular and functional roles of MicroRNAs in the progression of hepatocellular carcinoma - A review. Int. J. Mol. Sci, 21(21) : 8362.
Oura K,Morishita A,Tani J,Masaki T .2021 .Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: A review. Int. J. Mol. Sci, 22(11) : 5801.
Pallasch FB,Schumacher U .2020 .Angiotensin inhibition, TGF-β and EMT in cancer. Cancers, 12(10) : 2785.
Roy M,Liang L,Xiao X,Feng P,Ye M,Liu J .2018 .Lycorine: A prospective natural lead for anticancer drug discovery. Biomed, 107 : 615-624.
Sartorius K,Sartorius B,Winkler C,Chuturgoon A,Makarova J .2018 .The biological and diagnostic role of miRNA's in hepatocellular carcinoma. Frontiers in bioscience (Landmark edition), 23(9) : 1701-1720.
Shen J,Zhang T,Cheng Z,Zhu N,Wang H,Lin L,Wang Z,Yi H,Hu M H .2018 .Lycorine inhibits glioblastoma multiforme growth through EGFR suppression. J. Exp. Clin. Cancer Res., 37(1) : 157.
Sun Y,Gu Y,Gao X,Jin X,Wink M,Sharopov FS,Yang L,Sethi G .2023 .Lycorine suppresses the malignancy of breast carcinoma by modulating epithelial mesenchymal transition and β-catenin signaling. Pharmacol. Res., 195 : 106866.
Wang F,Xie Z,Zhang N,Ding H,Xiong K,Guo L,Huang H,Wen Z H .2022 .Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway. , 13 : 1185-1197.
Wang N,Li P,Liu J,Wang Z J .2023 .MiR-29a-3p promotes nasal epithelial barrier dysfunction via direct targeting of CTNNB1-VCL module in allergic rhinitis. Int. Immunopharmacol., 120 : 110325.
Wang Y,Wang P,Zhao L,Chen X,Lin Z,Zhang L,Li Z L .2021 .Front Cell Dev Biol. , 9 : 679185.
Wen NY,Cai YL,Li FY,Ye H,Tang W,Cheng NS W .2022 .The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci. Trends, 16(1) : 20-30.
Wu F,Yang J,Shang G,Zhang Z,Niu S,Liu Y,Liu H,Jing J,Fang Y .2022 .Exosomal miR-224-5p from colorectal cancer cells promotes malignant transformation of human normal colon epithelial cells by promoting cell proliferation through downregulation of CMTM4. Oxid. Med, 5983629 : .
Xu J,Wang Y,Jiang J,Yin C,Shi B C .2023 .ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway. J. Transl. Med, 21(1) : 56.
Yu H,Qiu Y,Pang X,Li J,Wu S,Yin S,Han L,Zhang Y,Jin C,Gao X,Hu W,Wang T .2017 .Lycorine promotes autophagy and apoptosis via TCRP1/Akt/mTOR axis inactivation in human hepatocellular carcinoma. Mol. Cancer Ther, 16(12) : 2711-2723.
Zang CS,Huang HT,Qiu J,Sun J,Ge RF,Jiang LW .2020 .MiR-224-5p targets EGR2 to promote the development of papillary thyroid carcinoma. Eur. Rev. Med, 24(9) : 4890-4900.
Zhai J,Jiang JF,Shi L JF .2023 .Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1. Kaohsiung J Med Sci., 39 : 278-289.
Zhang L,Huang L,Liang H,Zhang R,Chen G,Pang Y,Feng Z Y .2017 .Clinical value and potential targets of miR-224-5p in hepatocellular carcinoma validated by a TCGA- and GEO- based study. Int. J. Clin. Exp, 10(9) : 9970-9989.
Zhou J,Wang H,Sun Q,Liu X,Wu Z,Wang X,Fang W,- W .2021 .-enriched exosomes promote tumorigenesis by directly targeting androgen receptor in non-small cell lung cancer. Mol. Ther. Nucleic Acids, 23 : 1217-1228.
0

Citations

0

Downloads

155

Views